A multidrug resistance transporter from human MCF-7 breast cancer cells
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent reduction in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein. RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells. The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP). Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells. BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Current protocols in molecular biology
Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,205
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction
Liang, P., & Pardee, A. B. (1992) · Science · doi:10.1126/science.1354393 · Cited by 4,984
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Isolation and expression of a complementary DNA that confers multidrug resistance
Gros, P., Neriah, Y. B., Croop, J. M., & Housman, D. E. (1986) · Nature · doi:10.1038/323728a0 · Cited by 797
Biedler, J. L., & Riehm, H. (1970) · PubMed · Cited by 747
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
Ling, V., & Thompson, L. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830114 · Cited by 686
Sex Limited Inheritance in Drosophila
Morgan, T. H. (1910) · Science · doi:10.1126/science.32.812.120 · Cited by 616
Sex-linked inheritance in Drosophila
Morgan, T. H., & Bridges, C. B. (1916) · Carnegie Institution of Washington eBooks · doi:10.5962/bhl.title.54326 · Cited by 589
Research works printed but not linked: 12
- D Kessel, V Botterill, I Wodinsky Cancer Res 28, 938–941 (1968).
- J L Biedler, H Riehm Cancer Res 30, 1174–1184 (1970).
- J S Lee, S Scala, Y Matsumoto, B Dickstein, R Robey, Z Zhan, G Altenberg, S E Bates J Cell Biochem 65, 513–526 (1997). · doi:10.1002/(sici)1097-4644(19970615)65:4<513::aid-jcb7>3.0.co;2-r
- L A Doyle, D D Ross, R Sridhara, A T Fojo, S H Kaufmann, E J Lee, C A Schiffer Br J Cancer 71, 52–58 (1995). · doi:10.1038/bjc.1995.11
- P Liang, L Averboukh, K Keyomarsi, R Sager, A Pardee Cancer Res 52, 6966–6968 (1992).
- D D Ross, L A Doyle, C A Schiffer, E J Lee, C E Grant, S P C Cole, R G Deeley, W Yang, Y Tong Leukemia 10, 48–55 (1996).
- P M Bingham, R Levis, G M Rubin Cell 25, 693–704 (1981). · doi:10.1016/0092-8674(81)90176-8
- H Chen, C Rossier, M D Lalioti, A Lynn, A Chakravarti, G Perrin, S E Antonarkis Am J Hum Genet 59, 66–75 (1996).
- E L Pugh, S J Wakil J Biol Chem 240, 4727–4733 (1965). · doi:10.1016/s0021-9258(18)97016-x
- J K M Rao, P Garos Biochim Biophys Acta 899, 179–214 (1986).
- D D Ross, Y Gao, Y Yang, J Leszyk, J Shively, L A Doyle Cancer Res 57, 5460–5464 (1997).
- H Kawaharata, Y Hinoda, F Itoh, T Endo, S Oikawa, H Nakazato, K Imai Int J Cancer 72, 377–382 (1997). · doi:10.1002/(sici)1097-0215(19970717)72:2<377::aid-ijc29>3.0.co;2-b
Cited by
Items 201–209 of 209
An, R., Hagiya, Y., Tamura, A., Li, S., Saito, H., Tokushima, D., & Ishikawa, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9738-5 · Cited by 34
Progress in the Molecular Characterization of Hepatobiliary Transporters
Keppler, D. (2017) · Digestive Diseases · doi:10.1159/000450911 · Cited by 33
Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response
Brackman, D. J., & Giacomini, K. M. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.903 · Cited by 31
Identification of gene expression profiles predicting tumor cell response to L-alanosine
Efferth, T., Gebhart, E., Ross, D. D., & Sauerbrey, A. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00341-1 · Cited by 29
Self-citationZeng, F., Wang, F., Zheng, Z., Chen, Z., Wah To, K. K., Zhang, H., Han, Q., & Fu, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.008 · Cited by 26
Zhang, W., Oh, J.-H., Zhang, W., Rathi, S., Le, J., Talele, S., Sarkaria, J. N., & Elmquist, W. F. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03574-1 · Cited by 19
“After the discovery of P-gp and MRPs, breast cancer resistance protein (BCRP, ABCG2) was identified in a human breast cancer subline that exhibits multidrug resistance in the absence of P-gp and MRP1 overexpression [68].”
Structural Analysis of Cholesterol Binding and Sterol Selectivity by ABCG5/G8
(2022) · doi:10.1016/j.jmb.2022.167795 · Cited by 18
Tamura, A., An, R., Hagiya, Y., Hoshijima, K., Yoshida, T., Mikuriya, K., & Ishikawa, T. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.3.255 · Cited by 16
Saito, H., An, R., Hirano, H., & Ishikawa, T. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.72 · Cited by 7
Metadata
- Authors
- Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-12-22
- Volume
- 95
- Issue
- 26
- Pages
- 15665-15670
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2142024216
- Cited by
- 2,322
- References
- 16
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.